Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $122,903 | 41 | 69.3% |
| Consulting Fee | $23,908 | 12 | 13.5% |
| Travel and Lodging | $16,373 | 47 | 9.2% |
| Food and Beverage | $10,188 | 186 | 5.7% |
| Honoraria | $4,000 | 2 | 2.3% |
| Unspecified | $70.00 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $68,210 | 57 | $0 (2024) |
| Astellas Pharma US Inc | $34,551 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $29,973 | 41 | $0 (2024) |
| PFIZER INC. | $12,225 | 11 | $0 (2023) |
| Merck Sharp & Dohme LLC | $11,169 | 15 | $0 (2024) |
| Janssen Global Services, LLC | $6,089 | 6 | $0 (2024) |
| GENZYME CORPORATION | $5,214 | 6 | $0 (2019) |
| Photocure Inc | $3,881 | 19 | $0 (2024) |
| IMMUNITYBIO, INC. | $1,520 | 2 | $0 (2024) |
| Boston Scientific Corporation | $1,221 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,712 | 45 | Janssen Biotech, Inc. ($2,708) |
| 2023 | $10,113 | 55 | Merck Sharp & Dohme LLC ($6,324) |
| 2022 | $4,356 | 28 | Janssen Biotech, Inc. ($1,614) |
| 2021 | $2,509 | 5 | Janssen Biotech, Inc. ($2,400) |
| 2020 | $7,241 | 8 | Janssen Biotech, Inc. ($6,879) |
| 2019 | $22,692 | 24 | Astellas Pharma US Inc ($10,637) |
| 2018 | $112,878 | 104 | Janssen Scientific Affairs, LLC ($65,332) |
| 2017 | $7,940 | 20 | Janssen Biotech, Inc. ($7,132) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $53.53 | General |
| Category: LithoVue_URO | ||||||
| 12/17/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $135.91 | General |
| Category: AMS 700_URO | ||||||
| 12/13/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $1,665.00 | General |
| 12/05/2024 | Janssen Global Services, LLC | — | Food and Beverage | In-kind items and services | $140.20 | General |
| 12/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $38.40 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $37.47 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: HORMONE THERAPY | ||||||
| 12/04/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $149.12 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| 11/18/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | — | Consulting Fee | Cash or cash equivalent | $817.50 | General |
| 10/29/2024 | Janssen Biotech, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,090.00 | General |
| 10/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $100.84 | General |
| Category: Oncology | ||||||
| 10/21/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Immunotherapy | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: HORMONE THERAPY | ||||||
| 09/10/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $124.60 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $121.44 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 07/10/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: UROLOGY | ||||||
| 07/03/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $49.15 | General |
| Category: LithoVue_URO | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| None | Astellas Pharma Global Development | $70.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 290 | 358 | $70,543 | $24,519 |
| 2022 | 16 | 690 | 783 | $473,547 | $68,769 |
| 2021 | 14 | 498 | 566 | $303,086 | $50,864 |
| 2020 | 18 | 780 | 866 | $409,314 | $70,270 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 30 | 40 | $25,739 | $7,749 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 109 | $17,905 | $7,327 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 39 | $8,241 | $3,857 | 46.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $8,551 | $2,693 | 31.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 24 | $3,582 | $1,557 | 43.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 25 | $4,270 | $985.77 | 23.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 58 | 65 | $1,395 | $221.65 | 15.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 18 | 19 | $860.00 | $127.54 | 14.8% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 15 | 15 | $121,800 | $15,286 | 12.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 135 | 167 | $24,905 | $8,011 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 85 | 110 | $23,050 | $7,992 | 34.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 79 | 94 | $65,800 | $5,041 | 7.7% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2022 | 15 | 16 | $45,272 | $4,819 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 46 | 46 | $14,000 | $4,499 | 32.1% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 41 | 42 | $20,070 | $4,120 | 20.5% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2022 | 11 | 11 | $33,000 | $3,093 | 9.4% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2022 | 14 | 15 | $21,150 | $2,778 | 13.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 21 | 27 | $69,563 | $2,425 | 3.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 11 | 11 | $6,237 | $2,341 | 37.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 30 | 30 | $6,295 | $1,943 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 28 | $4,397 | $1,897 | 43.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2022 | 48 | 50 | $5,075 | $1,331 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,038 | $1,324 | 43.6% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 46 | 47 | $4,710 | $1,166 | 24.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 21 | 29 | $2,655 | $578.53 | 21.8% |
About Dr. Edouard Trabulsi, M.D
Dr. Edouard Trabulsi, M.D is a Urology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215956974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edouard Trabulsi, M.D has received a total of $177,442 in payments from pharmaceutical and medical device companies, with $9,712 received in 2024. These payments were reported across 289 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($122,903).
As a Medicare-enrolled provider, Trabulsi has provided services to 2,258 Medicare beneficiaries, totaling 2,573 services with total Medicare billing of $214,422. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Philadelphia, PA
- Active Since 07/19/2006
- Last Updated 02/25/2014
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1215956974
Products in Payments
- Erleada (Drug) $73,407
- XTANDI (Drug) $24,522
- ERLEADA (Drug) $13,953
- JEVTANA (Drug) $5,135
- ENTEREG (Drug) $4,797
- Cysview (Drug) $3,504
- ANKTIVA (Drug) $1,520
- LithoVue (Device) $428.57
- AQUABEAM ROBOTIC SYSTEM (Device) $407.80
- ILLUCCIX (Drug) $393.22
- CYSVIEW (Drug) $377.33
- ORGOVYX (Drug) $333.76
- SpaceOAR VUE System - 10mL (Device) $298.48
- UROLIFT (Device) $275.76
- Xtandi (Drug) $226.78
- KEYTRUDA (Biological) $199.86
- AMS 700 (Device) $178.48
- BALVERSA (Drug) $147.57
- General - Erectile Dysfunction (Device) $129.10
- Bard Urinary Drainage Bag (Device) $102.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Philadelphia
Dr. Daniel Eun, M.d, M.D
Urology — Payments: $382,660
Paul Chung, M.d, M.D
Urology — Payments: $251,745
Dr. Leonard Gomella, M.d, M.D
Urology — Payments: $248,176
Dr. Jay Simhan, M.d, M.D
Urology — Payments: $190,984
Robert Uzzo, Md02041967, MD02041967
Urology — Payments: $188,129
William Jaffe, Md, MD
Urology — Payments: $131,024